Cargando…

The Diagnostic Role of (18)F-Choline, (18)F-Fluciclovine and (18)F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis

BACKGROUND: Diagnosing the biochemical recurrence (BCR) of prostate cancer (PCa) is a clinical challenge, and early detection of BCR can help patients receive optimal treatment. We conducted a meta-analysis to define the diagnostic accuracy of PET/CT using (18)F-labeled choline, fluciclovine, and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rang, Shen, Guohua, Huang, Mingxing, Tian, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249319/ https://www.ncbi.nlm.nih.gov/pubmed/34222008 http://dx.doi.org/10.3389/fonc.2021.684629

Ejemplares similares

Detection of Recurrent Prostate Cancer With (18)F-Fluciclovine PET/MRI
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2020)

Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer
por: Farkas, Amy B., et al.
Publicado: (2021)

(18)F-Fluciclovine ((18)F-FACBC) PET imaging of recurrent brain tumors
por: Michaud, Laure, et al.
Publicado: (2019)

(18)F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
por: Rais-Bahrami, Soroush, et al.
Publicado: (2021)

Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
por: Zhou, Xing, et al.
Publicado: (2021)

Texture Analysis of F-18 Fluciclovine PET/CT to Predict Biochemically Recurrent Prostate Cancer: Initial Results
por: Kang, Hakmook, et al.
Publicado: (2020)

F-18 Fluciclovine PET-CT Findings and Pseudoprogression on Immunotherapy
por: Poindexter, Bradley C, et al.
Publicado: (2022)

Glioblastoma PET/MRI: kinetic investigation of [(18)F]rhPSMA-7.3, [(18)F]FET and [(18)F]fluciclovine in an orthotopic mouse model of cancer
por: Lindemann, Marcel, et al.
Publicado: (2022)

Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
por: Stokke, Caroline, et al.
Publicado: (2022)

Diagnostic accuracy of [(18)F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer
por: Mingels, Clemens, et al.
Publicado: (2022)

[(18)F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients
por: Nappi, Anna Giulia, et al.
Publicado: (2022)

Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
por: Rahbar, Kambiz, et al.
Publicado: (2018)

The Heterogeneous Metabolic Patterns of Ganglia in (68)Ga-PSMA, (11)C-choline, and (18)F-FDG PET/CT in Prostate Cancer Patients
por: Shi, Yiping, et al.
Publicado: (2021)

Understanding and Improving (18)F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer
por: Lowentritt, Benjamin H., et al.
Publicado: (2020)

Evaluation of 18F-DCFPyL PSMA PET/CT for Prostate Cancer: A Meta-Analysis
por: Pan, Ke-Hao, et al.
Publicado: (2021)

Meta-analysis of (18) F-PSMA-1007 PET/CT, (18) F-FDG PET/CT, and (68)Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
por: Yu, Wenxiao, et al.
Publicado: (2023)

The Role of [(18)F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [(11)C]Choline PET/CT and Histopathological Analysis
por: Zanoni, Lucia, et al.
Publicado: (2021)

Head-to-Head Comparison of [(18)F]F-choline and Imaging of Prostate-Specific Membrane Antigen, Using [(18)F]DCFPyL PET/CT, in Patients with Biochemical Recurrence of Prostate Cancer
por: García-Zoghby, Laura, et al.
Publicado: (2023)

Cost–consequence analysis of (18)F-fluciclovine for the staging of recurrent prostate cancer
por: Jensen, Ivar S, et al.
Publicado: (2020)

Impact of (18)F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy
por: Payne, Heather, et al.
Publicado: (2021)

Imaging Glioblastoma With (18)F-Fluciclovine Amino Acid Positron Emission Tomography
por: Scarpelli, Matthew L., et al.
Publicado: (2022)

(18)F-PSMA-1007 PET in Biochemical Recurrent Prostate Cancer: An Updated Meta-Analysis
por: Ferrari, Matteo, et al.
Publicado: (2021)

Simultaneous (18)F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
por: Esmaeili, Morteza, et al.
Publicado: (2018)

A Prospective Study on (18)F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
por: Rousseau, Etienne, et al.
Publicado: (2019)

Evaluation of (18)F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
por: Zhou, Xing, et al.
Publicado: (2021)

Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma
por: Hodolic, Marina
Publicado: (2010)

Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
por: Bach-Gansmo, Tore, et al.
Publicado: (2022)

Feasibility of Different Tumor Delineation Approaches for (18)F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

The (18)F-PSMA-1007 PET/CT performance on metastasis status and therapy assessment in oligo-metastasis prostate cancer
por: Wang, Zhuonan, et al.
Publicado: (2022)

Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation
por: Bergamini, Marco, et al.
Publicado: (2022)

[(18)F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis
por: Parent, Ephraim E., et al.
Publicado: (2020)

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2013)

[(18)F]Fluciclovine PET discrimination between high- and low-grade gliomas
por: Parent, Ephraim E., et al.
Publicado: (2018)

(18)F-Fluciclovine–Avid Axillary Lymph Nodes After COVID-19 Vaccination on PET/CT for Suspected Recurrence of Prostate Cancer
por: Peacock, Justin G., et al.
Publicado: (2022)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Case Report: (18)F-PSMA PET/CT May Improve the Clinical Management of Penile Metastases From Prostate Cancer
por: Fan, Junjie, et al.
Publicado: (2021)

(18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
por: Dong, Siying, et al.
Publicado: (2022)

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
por: Massaro, Arianna, et al.
Publicado: (2012)

Cerebellar Metastases from Prostate Cancer Detected by PET/CT with (18)F-Choline
por: Filippi, Luca, et al.
Publicado: (2022)

Characterising (18)F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
por: Scott, N. P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_st33gt58jmq6og77ors6fdscqg